EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Targeting cancer stem cells in multiple myeloma

Emine Gulsen Gunes, Metin Gunes, Jianhua Yu, Murali Janakiram

Trends in Cancer · 2024

DOI: 10.1016/j.trecan.2024.06.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2024. Verfasst von Emine Gulsen Gunes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA 91010, USA; Judy and Bernard B…. Hauptthemen laut MEDLINE: Multiple Myeloma, Neoplastic Stem Cells, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Multiple Myeloma Research Foundation, Leukemia & Lymphoma Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is a hematological malignancy of bone marrow (BM) plasma cells with excessive clonal expansion and is associated with the overproduction of light-chain or monoclonal immunoglobulins (Igs). MM remains incurable, with high rates of relapses and refractory disease after first-line treatment. Cancer stem cells (CSCs) have been implicated in drug resistance in MM; however, the evidence for CSCs in MM is not adequate, partly due to a lack of uniformity in the definitions of multiple myeloma stem cells (MMSCs). We review advances in understanding MMSCs and their role in drug resistance to MM therapies. We also discuss novel therapeutic strategies to overcome MMSC-mediated relapses and drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaNeoplastic Stem CellsDrug Resistance, NeoplasmHumansAntineoplastic AgentsMolecular Targeted TherapyAnimals

Stichwörter der Autor:innen

cancer stem cellsdrug resistancemultiple myelomarefractoryrelapse

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA 91010, USA; Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Los Angeles…
  • Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA 91010, USA.
  • Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA 91010, USA; Department of Immuno-Oncology, Beckman Research Institute, Los Angeles, CA 91010, USA; H…
  • Department of Hematology, Division of Myeloma, City of Hope National Medical Center, Los Angeles, CA 91010, USA.

Förderung

  • Multiple Myeloma Research Foundation
  • Leukemia & Lymphoma Society

Zitieren

APA

Gunes, E. G., Gunes, M., Yu, J., & Janakiram, M. (2024). Targeting cancer stem cells in multiple myeloma. Trends in Cancer. https://doi.org/10.1016/j.trecan.2024.06.002

Vancouver

Gunes EG, Gunes M, Yu J, Janakiram M. Targeting cancer stem cells in multiple myeloma. Trends in Cancer. 2024. doi:10.1016/j.trecan.2024.06.002

BibTeX
@article{Gunes2024,
  author = {Gunes, Emine Gulsen and Gunes, Metin and Yu, Jianhua and Janakiram, Murali},
  title = {Targeting cancer stem cells in multiple myeloma},
  journal = {Trends in Cancer},
  year = {2024},
  doi = {10.1016/j.trecan.2024.06.002}
}
Kostenlos starten →